UPDATE - Conexeu Sciences Initiates Preclinical Development Program for B.R.E.A.S.T.™ Bioregenerative Matrix Platform with Wake Forest Institute for Regenerative Medicine

Go back to UPDATE - Conexeu Sciences Initiates Preclinical Development Program for B.R.E.A.S.T.™ Bioregenerative Matrix Platform with Wake Forest Institute for Regenerative Medicine
(NASDAQ: CNXU) Delayed: 12.18 --0 (-0%)
Previous Close $12.18    52 Week High
Open $12.18    52 Week Low
Day High $12.18    P/E N/A 
Day Low $12.18    EPS
Volume 262